DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Myphetane DX (Brompheniramine Maleate / Pseudoephedrine Hydrochloride / Dextromethorphan Hydrobromide) - Published Studies

 
 



Myphetane DX Related Published Studies

Well-designed clinical trials possibly related to Myphetane DX (Brompheniramine / Pseudoephedrine / Dextromethorphan)

Hypertonic dextrose versus corticosteroid local injection for the treatment of osteoarthritis in the first carpometacarpal joint: a double-blind randomized clinical trial. [2014]

Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies. [2011.07]

Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. [2011.03.19]

Safety and reliability of the insertable Reveal XT recorder in patients undergoing 3 Tesla brain magnetic resonance imaging. [2011.03]

Clinical observation on the effect of dexamethasone and Chinese herbal decoction for purgation in severe acute pancreatitis patients. [2011.02]

Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion. [2011.01]

Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. [2011]

The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass. [2009.06]

Dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa. [2008.08]

The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy. [2008.05]

Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design. [2007.08]

[Comparison between two methods for hemodynamic measurement: thermodilution and oesophageal doppler] [2007.07]

Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. [2006.12]

Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer. [2006.09.20]

Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study. [2006.07]

Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. [2006.03]

Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy. [2005.08]

[Clinical study on effect of tuihuan decoction rectoclysis in hyperbilirubinemia of newborn] [2005.06]

Effects of dexamethasone and growth hormone treatment on hepatic gluconeogenic enzymes in calves. [2005.06]

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. [2005.03]

Aerobic and functional capacity in a group of healthy women: reference values and repeatability. [2004.11]

A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer. [2004.10]

Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers. [2004.10]

Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients. [2004.06]

Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot. [2004.02]

A refined technique for determining the respiratory gas exchange responses to anaerobic metabolism during progressive exercise - repeatability in a group of healthy men. [2004.01]

The response of the hepatic insulin-like growth factor system to growth hormone and dexamethasone in calves. [2003.12]

Decision-making in follow-up after endovascular aneurysm repair based on diameter and volume measurements: a blinded comparison. [2003.08]

Intensive care information system reduces documentation time of the nurses after cardiothoracic surgery. [2003.01]

Noninvasive vs. conventional mechanical ventilation in patients with chronic obstructive pulmonary disease after failure of medical treatment in the ward: a randomized trial. [2002.12]

First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. [2002.05.21]

Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. [2002.05]

Dextranomer/hyaluronic acid copolymer implantation for vesico-ureteral reflux: a randomized comparison with antibiotic prophylaxis. [2002.02]

Impairment of renal function after cardiopulmonary bypass is not influenced by dopexamine. [2001.03]

CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations. [2000.01]

Preclinical and clinical trials of topoisomerase inhibitors. [2000]

Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study. [1999.12]

Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers. [1999.09]

The VECAT study: methodology and statistical power for measurement of age-related macular features. Vitamin E, Cataract, and Age-related Maculopathy Study. [1999.09]

CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline. [1999.04]

A nitrogen-free hypocaloric diet and recombinant human growth hormone stimulate postoperative protein synthesis: fasted and fed leucine kinetics in the surgical patient. [1997.07]

Comparison of three methods to estimate heparin loading dose for cardiopulmonary bypass. [1996.06]

Plasma bradykinin levels during hemodialysis with PAN DX and polysulfone membranes with and without concurrent ACE inhibitor. [1995.11]

A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin. [1994.11]

Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. [1994]

The effects of phonophoresis with corticosteroids: a controlled pilot study. [1993.11]

A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer. [1989.12.15]

Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli. [1984.05]

Other possibly related research studies

Lack of Effect of DX-619, a Novel des-Fluoro(6)-Quinolone, on Glomerular Filtration Rate as Measured by Serum Clearance of Cold Iohexol. [2007.03.19]

Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. [2007.03]

Comparison of digital and film stereo photography of the optic nerve in the evaluation of patients with glaucoma. [2006.12]

Danaparoid sodium reduces ischemia/reperfusion-induced liver injury in rats by attenuating inflammatory responses. [2007.01]

Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis. [2007.02]

Treatment of stress urinary incontinence with non-animal stabilised hyaluronic acid/dextranomer (NASHA/Dx) gel : An analysis of utility and cost. [2006]

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX. [2006.11]

Effect of glucocorticoid pretreatment on oxidative liver injury and survival in jaundiced rats with endotoxin cholangitis. [2006.12]

In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs. [2007.02.01]

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. [2006.10.13]

Accelerated repair of a bone defect with a synthetic biodegradable bone-inducing implant. [2006.10]

Glucocorticoid pretreatment suppresses chemokine expression and inflammatory cell infiltration in cholestatic rats receiving biliary intervention. [2006.10]

Magnetic resonance imaging to evaluate NASHA/Dx gel (Zuidex) for stress urinary incontinence. [2006.10]

Conversion from cyclosporine to mycophenolate mofetil improves expression of A20 in the rat kidney allografts undergoing chronic rejection. [2006.09]

The so-called stunning of thyroid tissue. [2006.09]

Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles. [2006.10.12]

The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. [2006.09]

Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. [2006.09]

Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon. [2006.08]

Universal approximation using incremental constructive feedforward networks with random hidden nodes. [2006.07]

Dexamethasone protects against Cisplatin-induced activation of the mitochondrial apoptotic pathway in human osteosarcoma cells. [2006.08]

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy. [2007.02]

Mode of interaction between butyroyloxymethyl-diethyl phosphate (AN-7) and doxorubicin in MCF-7 and resistant MCF-7/Dx cell lines. [2006.10]

The economic impact of children dispensed asthma medications without an asthma diagnosis. [2006.06]

Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. [2006.06.09]

The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. [2006.06]

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. [2006]

Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation. [2006.08]

[Paraurethral abscess developing after mid-urethral Zuidex-injection in women with stress urinary incontinence -- management of complications and retrospective comparison with bladder neck located injection technique] [2006.04]

Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts. [2006.04]

Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. [2006.07]

A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate. [2006.06.06]

Single center experience with endoscopic management of vesicoureteral reflux in children. [2006.05]

Effects of mistletoe extract on murine thymocytes in vivo and on glucocorticoid-induced cell count reduction. [2006.02]

Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2. [2006.07]

Chemotherapy for advanced pancreatic cancer. [2006.04]

Risk assessment of human myelotoxicity of anticancer drugs: a predictive model and the in vitro colony forming unit granulocyte/macrophage (CFU-GM) assay. [2006.02]

Antigen from the anterior chamber of the eye travels in a soluble form to secondary lymphoid organs via lymphatic and vascular routes. [2006.03]

The effects of static muscular contraction on blood pressure, heart rate, pain ratings and pressure pain thresholds in healthy individuals and patients with fibromyalgia. [2007.01]

A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein-2: A potential treatment for infected bone defects. [2006.03]

New contralateral vesicoureteral reflux following dextranomer/hyaluronic Acid implantation: incidence and identification of a high risk group. [2006.03]

Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines. [2006.05.01]

Phenotypical expression of CYP2D6 in amerindians of tepehuano origin from Durango, Mexico. [2005]

In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model. [2006.01]

Small molecule coagulation cascade inhibitors in the clinic. [2005]

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. [2005.12.19]

Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates. [2005.12]

In vitro effects of bethanechol on equine gastrointestinal contractility and functional characterization of involved muscarinic receptor subtypes. [2005.12]

Periurethral granuloma following injection with dextranomer/hyaluronic acid copolymer for stress urinary incontinence. [2007.01]

Prevention of doxorubicin-induced cardiotoxicity by melatonin. [2006.01]

Heterogeneity of synthetic factor Xa inhibitors. [2005]

Gateways to clinical trials. [2005.10]

Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). [2006.03]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017